CAMRESE
Dead / Cancelled — Cancelled — Section 8 (as of 06 May 2022)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85036659
- Registration number
- 4046272
- Mark type
- Stylized text
- Filed
- 12 May 2010
- Published for opposition
- 26 Oct 2010
- Registered
- 25 Oct 2011
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, oral contraceptives, hormone replacement therapy preparations and pharmaceutical preparations, namely, hormonal agents for treating hormone disorders and conditions related to women's health
Owner
- Teva Pharmaceuticals USA, Inc., North Wales, PA, US
- Teva Pharmaceuticals USA, Inc., North Wales, PA, US
- Teva Pharmaceuticals USA, Inc., North Wales, PA, US
Prosecution history
- 06 May 2022 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 25 Oct 2020 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 17 Oct 2017 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 17 Oct 2017 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 17 Oct 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 25 Sept 2017 — TEAS SECTION 8 & 15 RECEIVED
- 25 Sept 2017 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Oct 2016 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 25 Oct 2011 — REGISTERED-PRINCIPAL REGISTER
- 21 Sept 2011 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Sept 2011 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 06 Sept 2011 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Aug 2011 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Aug 2011 — USE AMENDMENT FILED
- 01 Aug 2011 — TEAS STATEMENT OF USE RECEIVED